Part,  Chapter, Paragraph

  1   II,     4.  1    |               for at least the last 6 months, because of health problems (
  2   II,     5.  1.  1|             toddlers usually after 10 months of age.~Liver Cirrhosis~
  3   II,     5.  4.  2|               HbA1c tested in last 12 months~16~Percent of diabetic subjects
  4   II,     5.  4.  2|          lipid profile in the last 12 months~14~Percent of diabetic subjects
  5   II,     5.  4.  2|        subjects tested in the last 12 months with total cholesterol>5
  6   II,     5.  4.  2|        subjects tested in the last 12 months with LDL>2.6 mmol/l (>3
  7   II,     5.  4.  2|        subjects tested in the last 12 months with HDL<1.15 mmol/l (<1.
  8   II,     5.  4.  2|        subjects tested in the last 12 months with triglycerides >2.3
  9   II,     5.  4.  2|       microalbuminuria in the last 12 months~12~Percent of diabetic subjects
 10   II,     5.  4.  2|       microalbuminuria in the last 12 months, with an abnormal level~
 11   II,     5.  4.  2|       pressure measurement in last 12 months~14~Percent of of diabetic
 12   II,     5.  4.  2|               pressure in the last 12 months showing a value >140/90~
 13   II,     5.  4.  2|             inspection in the last 12 months~11~Percent of diabetic subjects
 14   II,     5.  4.  2|        subjects tested in the last 12 months, with proliferative retinopathy
 15   II,     5.  4.  2|  proliferative retinopathy in last 12 months~6~Percent of diabetic subjects
 16   II,     5.  4.  2|            received laser treatment<3 months after diagnosis of proliferative
 17   II,     5.  4.  2|           serum creatinine in last 12 months~13~Percent of diabetic subjects
 18   II,     5.  4.  2|    haemoglobin (HbA1c) in the last 12 months is measured as the percentage
 19   II,     5.  4.  2|               measured in the last 12 months. EUCID results were obtained
 20   II,     5.  4.  2|            cholesterol in the last 12 months is an important parameter
 21   II,     5.  4.  2|     cholesterol tested in the last 12 months.~Total cholesterol level>
 22   II,     5.  4.  2|         cholesterol tested in last 12 months showing a total cholesterol
 23   II,     5.  4.  2|            cholesterol in the last 12 months is another important aspect
 24   II,     5.  4.  2| LDL-cholesterol tested in the last 12 months.~LDL cholesterol level >
 25   II,     5.  4.  2| LDL-cholesterol tested in the last 12 months and presenting a value above
 26   II,     5.  4.  2|            cholesterol in the last 12 months is also taken as an indicator
 27   II,     5.  4.  2| LDL-cholesterol tested in the last 12 months.~HDL cholesterol level <
 28   II,     5.  4.  2| HDL-cholesterol tested in the last 12 months and HDL cholesterol below
 29   II,     5.  4.  2|          triglycerides in the last 12 months is the last important parameter
 30   II,     5.  4.  2|   triglycerides tested in the last 12 months.~Triglycerides level >2.
 31   II,     5.  4.  2|         cholesterol tested in last 12 months showing a total cholesterol
 32   II,     5.  4.  2|    proteinuria exists) in the last 12 months.~An abnormal level of albuminuria
 33   II,     5.  4.  2|         proteinuria tested in last 12 months with a microalbuminuria
 34   II,     5.  4.  2|               measured in the last 12 months. The median is 95% for Germany.
 35   II,     5.  4.  2|               measured in the last 12 months and reported a diastolic
 36   II,     5.  4.  2|           fundus inspected in last 12 months. This indicator is the only
 37   II,     5.  4.  2|              inspected in the last 12 months and were diagnosed with
 38   II,     5.  4.  2|              inspected in the last 12 months and were diagnosed with
 39   II,     5.  4.  2|              laser treatment within 3 months.~Control of serum creatinine
 40   II,     5.  4.  2|             tested during the last 12 months.~Renal failure is measured
 41   II,     5.  4.  2|      creatinine tested in the last 12 months and End Stage Renal Failure (
 42   II,     5.  4.  3|    haemoglobin (HbA1c) in the last 12 months. OECD data (Armesto et al,
 43   II,     5.  4.  3|            cholesterol in the last 12 months. EUCID crude data from 12
 44   II,     5.  4.  3|            cholesterol in the last 12 months. The EUCID indicator varies
 45   II,     5.  4.  3|            cholesterol in the last 12 months. The EUCID indicator varies
 46   II,     5.  4.  3|          triglycerides in the last 12 months. EUCID crude data from 11
 47   II,     5.  4.  3|              inspected in the last 12 months and were diagnosed with
 48   II,     5.  5.  1|             mental disorder during 12 months, ESEMeD Study.~ ~Anxiety
 49   II,     5.  5.  3|              from Germany from the 12-months period between July 2002
 50   II,     5.  5.  3|               in these surveys was 12 months (Kohn et al, 2004).~The
 51   II,     5.  5.  3|               discontinuation over 12 months in patients with first-episode
 52   II,     5.  5.  3|              between six and eighteen months of age. Some of their characteristic
 53   II,     5.  5.  3|           deterioration, over several months of intellectual, social
 54   II,     5.  5.  3|              seizures a month over 18 months or longer.~ ~
 55   II,     5.  5.  3|          probability of illness by 24 months was 86% in patients with
 56   II,     5.  5.  3|              ban)~___ __~Belgium I 12 months First unprovoked seizure (
 57   II,     5.  5.  3|           First unprovoked seizure (6 months)~ First seizure, idiopathic (
 58   II,     5.  5.  3|          First seizure, idiopathic (3 months)~ Seizures not impairing
 59   II,     5.  5.  3|              not impairing driving (3 months)~ Seizures during sleep,
 60   II,     5.  5.  3|            pattern established~ by 24 months~ II 120 months (no AED;
 61   II,     5.  5.  3|     established~ by 24 months~ II 120 months (no AED; First unprovoked
 62   II,     5.  5.  3|        seizure (2 years)~Croatia I 24 months Ban in people taking drugs
 63   II,     5.  5.  3|             with driving~Denmark I 12 months Seizures during sleep (license
 64   II,     5.  5.  3|           First unprovoked seizure (6 months)~ II 60 months (taxi 120;
 65   II,     5.  5.  3|             seizure (6 months)~ II 60 months (taxi 120; Must be off AED
 66   II,     5.  5.  3|             240) 5 years~Estonia I 24 months -~ II - Prohibited~Finland
 67   II,     5.  5.  3|               Prohibited~Finland I 12 months First unprovoked seizure
 68   II,     5.  5.  3|           normal~ diagnostic tests (3 months)~ Sporadic seizures (6 months)~
 69   II,     5.  5.  3|         months)~ Sporadic seizures (6 months)~ Myoclonias (dose)~ II -
 70   II,     5.  5.  3|                Prohibited~France I 12 months Seizures only on awakening~
 71   II,     5.  5.  3|           only on awakening~ II 24-60 months No seizures in previous
 72   II,     5.  5.  3|         previous 3 years~Germany I 12 months Single seizures or occasion-related
 73   II,     5.  5.  3|       occasion-related seizures~ (3-6 months)~ First seizure, idiopathic (
 74   II,     5.  5.  3|              seizure, idiopathic (3-6 months)~ Treatment stop (ban 3
 75   II,     5.  5.  3|                 Treatment stop (ban 3 months)~ II 60 months (no AED)
 76   II,     5.  5.  3|            stop (ban 3 months)~ II 60 months (no AED) First seizure,
 77   II,     5.  5.  3|               seizure, idiopathic (24 months)~Ireland I 12 months Seizures
 78   II,     5.  5.  3|               24 months)~Ireland I 12 months Seizures during sleep established
 79   II,     5.  5.  3|      established by 1 year~Italy I 24 months -~ II - Prohibited~Netherlands
 80   II,     5.  5.  3|           Prohibited~Netherlands I 12 months First unprovoked seizure (
 81   II,     5.  5.  3|           First unprovoked seizure (6 months)~ First unprovoked, idiopathic
 82   II,     5.  5.  3|     unprovoked, idiopathic seizure (3 months)~ Sporadic seizures (6 months)~
 83   II,     5.  5.  3|         months)~ Sporadic seizures (6 months)~ Myoclonias, single partial
 84   II,     5.  5.  3|            single partial seizures (3 months)~ Treatment stop/change (
 85   II,     5.  5.  3|          Treatment stop/change (ban 3 months)~ II 60 months (no AED;
 86   II,     5.  5.  3|          change (ban 3 months)~ II 60 months (no AED; Untreated first
 87   II,     5.  5.  3|             activity)~ ~ ~Norway I 12 months Drugs stolen or last seizure
 88   II,     5.  5.  3|     particular~ circumstances~ II 120 months (taxi) -~Sweden I 24 months
 89   II,     5.  5.  3|           months (taxi) -~Sweden I 24 months Single unprovoked seizure~
 90   II,     5.  5.  3|             unprovoked seizure~ II 60 months (taxi) -~Switzerland I 12
 91   II,     5.  5.  3|              taxi) -~Switzerland I 12 months -~United Kingdom I 12 months
 92   II,     5.  5.  3|          months -~United Kingdom I 12 months Seizures during sleep with
 93   II,     5.  5.  3|       established~ by 3 years~ II 120 months (no AED) Medical examination
 94   II,     5.  6.  3|               a median duration of 10 months. There is also an increased
 95   II,     5.  6.  3|               functional outcome at 6 months (Kaukonen et al, 1988; Sernbo
 96   II,     5.  6.  3|              is between 6 weeks and 3 months duration and chronic when
 97   II,     5.  6.  3|             when it lasts more than 3 months (Frymoyer, 1988). Frequent
 98   II,     5.  6.  3|           with 90% returning within 2 months (Woolf and Pfleger, 2003),
 99   II,     5.  6.  3|               return to work. After 6 months off work, less than 50%
100   II,     5.  7.  1|               persist for more than 3 months. The disease is categorized
101   II,     5.  7.  1|   abnormalities of the kidneys for >3 months, as manifested by:~1. Kidney
102   II,     5.  8.  6|            showed that in the last 12 months of life, decedents with
103   II,     5.  8.  7|            lung cancer in the last 12 months of life. Respir Med 102:
104   II,     5.  9. FB|              wheezing at the age of 3 months in breast-fed infants with
105   II,     5.  9. FB|            intervention beyond 4 to 6 months of age for the development
106   II,     5.  9. FB|               foods for at least four months in children has some protective
107   II,     5.  9.  3|              5.9.1. Wheeze in last 12 months in ECHRS and ISAAC phase
108   II,     5. 14.  2|            within the Previous Twelve Months~Proportion of population
109   II,     5. 14.  3|            within the previous twelve months~ ~In Eastern Europe, many
110   II,     6.  3.  4|             may last for six to eight months, and usually with a much
111   II,     6.  3.  4|            treatment for at least six months with a combination of antibiotics.
112   II,     6.  3.  6|             mean survival of about 14 months. The main suspected route
113   II,     8.  1.  2|              disability (LSHPD) for 6 months or more or expected to last
114   II,     8.  1.  2|            more or expected to last 6 months or more. The indicator used
115   II,     9        |              got drunk in the last 12 months peaks in Denmark (WHO/HSBC,
116   II,     9        |            used it in the previous 12 months. Regular use of cannabis (
117   II,     9        |              times in the previous 12 months) is highest (15% or over)
118   II,     9.  2.  3|               more in the previous 12 months (HBSC, 2004). Unintentional
119   II,     9.  2.  4|              got drunk in the last 12 months peaks in Denmark (WHO/HSBC,
120   II,     9.  2.  4|            used it in the previous 12 months. Regular use of cannabis (
121   II,     9.  2.  4|              times in the previous 12 months) is highest (15% or over)
122   II,     9.  2.  5|       exclusive breastfeeding for six months and continued breastfeeding,
123   II,     9.  3.  1|         occurred after 12 consecutive months of amenorrhea for which
124   II,     9.  3.  3|         coital act during the last 12 months;~· percentage of men who
125  III,    10.  2.  1|           once during the previous 12 months, and 65% had consumed alcohol
126  III,    10.  2.  1|        average during the previous 12 months Table 10.2.1.2.1. The proportion
127  III,    10.  3.  1|       measurement after the first six months of occupation is still recommended
128  III,    10.  3.  3|               that may last up to two months or even longer. Diphtheria
129  III,    10.  3.  3|             mean survival of about 14 months. The main suspected route
130  III,    10.  4.  1|      population by approximately nine months, which is comparable to
131  III,    10.  4.  1|            life expectancy of about 9 months for every EU citizen. Exposure
132  III,    10.  4.  2|             feeding for at least four months. Solid foods should not
133  III,    10.  4.  2|           residents: works started (9 months contract ongoing funded
134  III,    10.  4.  2|              be slaughtered after six months of age cannot make a distinction
135  III,    10.  4.  2|              it is reviewed every six months.~ ~The findings and conclusions
136  III,    10.  5.  3|        absence during the previous 12 months. Furthermore, perceived
137  III,    10.  5.  3|          problems at least once in 12 months (Table 10.5.3.1). This results
138  III,    10.  5.  3|            their jobs in the next six months.~The economic sectors most
139  III,    10.  5.  3|            their jobs in the next six months. Workers in education, health,
140  III,    10.  5.  3|               his job in the next six months compared to every tenth
141  III,    10.  6.  1|              members over the last 12 months. Another dimension that
142   IV,    12. 10    |      breastfeeding up to four and six months of age respectively~ ~Proportion
143   IV,    12. 10    |      breastfeeding up to four and six months of age respectively~ ~Domain
144   IV,    12. 10    |                during the last twelve months~Domain of objective 8~ ~